Citation Impact

Citing Papers

Vascular Klotho Deficiency Potentiates the Development of Human Artery Calcification and Mediates Resistance to Fibroblast Growth Factor 23
2012 Standout
EULAR recommendations for the management of primary small and medium vessel vasculitis
2008 Standout
A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies
2003 Standout
Peripheral Nerve Amyloidosis
1996
Oxidative stress, aging, and diseases
2018 Standout
Neuroendocrine mechanisms mediating awakening of the human gonadotropic axis in puberty
1996
Small-Vessel Vasculitis
1997 Standout
Plasma Exchange Treatment Improves Prognosis of Antineutrophil Cytoplasmic Antibody‐associated Crescentic Glomerulonephritis: A Case‐Control Study in 26 Patients from a Single Center
2003
Renal histopathology and clinical course in 94 patients with Wegener's granulomatosis
2001
Paraquat Poisonings: Mechanisms of Lung Toxicity, Clinical Features, and Treatment
2007 Standout
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
2008 Standout
Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1
2004
Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's granulomatosis classification criteria cohort
1996
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
2016 Standout
Vitamin D Deficiency
2007 Standout
Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease
2016
Renal and Extrarenal Effects of Gum Arabic (Acacia Senegal) - What Can be Learned from Animal Experiments?
2013 Standout
Wegener's granulomatosis: clinical course in 108 patients with renal involvement
2000
Cellular and molecular mechanisms of renal fibrosis
2011 Standout
Sexual Dysfunction in Men and Women With Chronic Kidney Disease and End-Stage Kidney Disease
2003
Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease
2010 Standout
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
Sexual Dysfunction in Uremia
1999
Positive classic antineutrophil cytoplasmic antibody (C‐ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3–related vasculitis
2004
Primary Care Physicians Who Treat Blacks and Whites
2004 Standout
Inhibition of Intestinal Sodium‐dependent Inorganic Phosphate Transport by Fibroblast Growth Factor 23
2005
ANCA-associated vasculitis with renal involvement: an outcome analysis
2004
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
2011 Standout
An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Long-term outcome in 155 patients
2000 Standout
Elevated Plasma Levels of Tumor Necrosis Factor (TNF)-α, Soluble TNF Receptors, Interleukin (IL)-6, and IL-IO in Patients with Hemorrhagic Fever with Renal Syndrome
1996
Systemic amyloidosis
2015 Standout
Chronic kidney disease: global dimension and perspectives
2013 Standout
FGF23 Fails to Inhibit Uremic Parathyroid Glands
2010
Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
2006 Standout
Hyperphosphataemia in Renal Failure
2003
Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis
1999
Therapy for the maintenance of remission in sixty‐five patients with generalized Wegener's granulomatosis. Methotrexate versus trimethoprim/sulfamethoxazole
1996
Epidemiology of Chronic Kidney Disease in Central and Eastern Europe
2008
Cyclosporin for the prevention of disease reactivation in relapsing ANCA-associated vasculitis
1998
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
2005 Standout
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement
2003
Chances of Renal Recovery for Dialysis-Dependent ANCA-Associated Glomerulonephritis
2007
Clinical and Histologic Determinants of Renal Outcome in ANCA-Associated Vasculitis
2006
RAGE and the pathogenesis of chronic kidney disease
2010
Long-term patient survival in ANCA-associated vasculitis
2010 Standout
Chronic Kidney Disease
2016 Standout
Molecular Mechanisms of Amyloidosis
2003 Standout
The Tubulointerstitial Nephritis and Uveitis Syndrome
2001
Nephrologist Care and Mortality in Patients With Chronic Renal Insufficiency
2002
Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study
2003
Relative in Vitro Efficacy of the Phosphate Binders Lanthanum Carbonate and Sevelamer Hydrochloride
2007 StandoutNobel
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Availability of renal replacement therapy in Central and Eastern Europe.
2009
Dialysis Dose and Intradialytic Hypotension: Results from the HEMO Study
2013 Standout
WEGENER'S GRANULOMATOSIS
1995
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Review of the Toxicology of Paraquat (1, 1′-Dimethyl-4, 4′-bipyridinium Chloride)
1979
Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop
2005 Standout
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
2005
Skeletal abnormalities in chronic renal insufficiency before and during maintenance hemodialysis
1973
Predictive value of initial histology and effect of plasmapheresis on long-term prognosis of rapidly progressive glomerulonephritis
2002
Light and electron microscopy immunohistochemical characterization of amyloid deposits
1997
The Timing of Specialist Evaluation in Chronic Kidney Disease and Mortality
2002
Bone metabolism and disease in chronic kidney disease
2003
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
2003 Standout

Works of E Ritz being referenced

[Acute interstitial pulmonary fibrosis in Paraquat poisoning. Clinico-anatomical observation of a case with fatal outcome].
1969
Beta-2-Microglobulin-Derived Amyloidosis: Onset, Distribution and Clinical Features in 13 Hemodialysed Patients
1992
Nephrologists neglect administration of betablockers to dialysed diabetic patients
1997
A 63bp Deletion in the Promoter of RAGE Correlates with a Decreased Risk for Nephropathy in Patients with Type 2 Diabetes
2004
Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group.
1996
Nephrology in the Baltic countries
1998
Severe hemorrhagic complications from infection with nephropathia epidemica strain of Hantavirus.
1992
Wegener's granulomatosis with renal involvement: patient survival and correlations between initial renal function, renal histology, therapy and renal outcome.
1991
How can we improve prognosis in diabetic patients with end-stage renal disease?
1999
Calcium absorption and excretion in the gut in chronic renal failure.
1971
Changes in the kinetics and biopotency of luteinizing hormone in hemodialyzed men during treatment with recombinant human erythropoietin.
1994
Akute granulomatöse interstitielle Nephritis mit Iritis: Mögliche Auslösung durch nicht-steroidale Antiphlogistika
2008
Abnormal Expression and Regulation of Vitamin D Receptor in Experimental Uremia
1996
Rankless by CCL
2026